Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 8, 2011


Waters this week named Albert Fornace's laboratory at Georgetown University Medical Center one of its Centers of Innovation and recognized Fornace and his fellow GUMC researcher Amrita Cheema for their metabolomics research.

Fornace is a professor of oncology at Georgetown and a professor of biochemistry and molecular and cellular biology at GUMC who studies stress signaling in cancer and other diseases.

With Fornace, Cheema is the co-director of the GUMC metabolomics program.

The Waters Centers of Innovation Program is meant to recognize and support the efforts of scientists using mass spec and LC to make scientific breakthroughs, the company said.

Radient Pharmaceuticals this week appointed Dilek Mir director of business development and investor relations.

Previously, Mir was the founder of ProteaSure, developer of a proteomic in vitro diagnostic for endometrial cancer.

Former president of Myriad Genetics, Gregory Critchfield, has been appointed chairman of the board of directors at Saladax Biomedical. Critchfield was president of Myriad until March 2010.

Previously, he was the chief medical and science officer at Corning Clinical Laboratories, which became Quest Diagnostics. He has also served as an independent director in industry associations and other life science diagnostic product and platform companies, including Integrated Diagnostics, Sera Prognostics, Metamark Genetics, Nodality, Biocius Life Sciences, and BioTrove.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.